2024 CTR Exam 3 Complete Questions & Answers (Solved) 100% Correct
- Sarcoma
Answer: Solid tumors of connective tissue.
- lymphomas & leukemia sarcomas
Answer: tend to spread by hematologic routes
- carcinomas spread via
Answer: lymphatics
- Adenocarcinoma are predominantly
Answer: glandular or ductal
- squamous cell carcinoma arise from
Answer: stratified squamous epithelium
- Extra lymphatic sites
Answer: stomach, skin, lungs
- Rituxumab
Answer: immunotherapy (lymphoma)
- lymphatic organs
Answer: lymph nodes, tonsils, Waldeyers ring, spleen, thymus, Peyer patches
- prognostic factors
Answer: lymphoma: HIV/AIDS, presence of B symptoms (Night sweats, unexplained weight loss, low grade fever), prognostic indices (IPI, FLIPI, IPS)
- Hormone therapy agents
Answer: prednisone, arimidex, lupron, letrizole
- chemotherapy (chemo)
Answer: cyclophosphamide, paclitaxel, taxotere, taxol,carbo- platin
- Immunotherapy
Answer: Rituxumab, herceptin (trastuzumab), 1 / 2
- control group
Answer: patients in a clinical trial that receive standard treatment
- protocol studies
Answer: systematic scientific test that evaluate new treatments or drugs and
different ways of using them in controlled clinical trial protocol studies
- single-blind study
Answer: patients are unaware of the treatment group to which they are assigned
- double blind study
Answer: both the patient and the attending doctor are unaware of the patient's
treatment group
- triple blind study
Answer: the patient the attending physician and the analysts do not know which
group the patient has been assigned
- clinical staging
Answer: information obtained before definitive treatment or within 4 months
whichever is shorter
- pathologic staging
Answer: information obtained through completion of definitive surgery as part of first course of treatment or within 4 months whichever is longer
20. FIGO
Answer: oldest staging system developed in the 1930s used for female reproductive sites
- single primary
Answer: a single lesion with multiple histologic types
- active follow up
Answer: direct contact with Physicians or patients or letters to other facilities
- passive follow up
Answer: methods that do not require patient or physician contact and would be
hospital readmissions or outpatient visits or other outside sources of information
- / 2